
The U.S. mergers and acquisitions (M&A) landscape remained robust through 2025, with total deal value nearing multiyear highs as corporate buyers and private equity firms pursued strategic growth amid economic uncertainties.
According to the latest M&A activity report from Ernst & Young (EY), companies completed a broad range of transactions in 2025 spanning technology, healthcare, and energy sectors. Dealmakers cited strong earnings, abundant capital, and strategic repositioning as key drivers.
“Despite macroeconomic headwinds, corporate acquirers and private investors remained active, recognizing opportunities in emerging markets and transforming industries,” the report said.
EY’s analysis showed that strategic buyers continued to dominate the U.S. M&A market, while private equity firms maintained elevated acquisition volumes supported by dry powder reserves and favorable financing conditions.
Many transactions reflected sectors where innovation and regulatory change are reshaping competitive landscapes. Technology acquisitions often focused on artificial intelligence (AI), cloud computing, and cybersecurity capabilities — areas where firms aim to bolster digital transformation.
Healthcare deals included pharmaceutical licensing agreements, healthcare service consolidations, and healthcare technology acquisitions, reflecting long-term demographic and cost management trends.
Energy sector activity was driven by both traditional oil and gas assets and renewable energy investments. Buyers sought to balance portfolios amid ongoing transition to cleaner energy sources.
The strong deal environment was underscored by several landmark transactions, including multibillion-dollar acquisitions of AI-focused firms and cross-border investments. While exact totals vary by source, analysts noted that overall U.S. M&A value in 2025 remained among the highest levels recorded in recent years.
Corporate executives cited steady earnings reports and targeted capital allocation as confidence boosters for pursuing deals. Access to financing, including leveraged loans and bonds, continued to support transactions despite occasional volatility in credit markets.
Looking toward 2026, EY’s outlook anticipates continued deal momentum. The firm forecasts that digitization imperatives, supply chain restructuring, and sustainability commitments will catalyze further transactions.
“Companies are prioritizing growth through acquisition as they adapt to competitive pressures and technological change,” said an EY partner specializing in transaction advisory services.
Regulatory dynamics are expected to shape deal activity in the year ahead. Antitrust scrutiny from U.S. regulators, particularly in technology and healthcare sectors, has heightened due diligence requirements and extended timelines for some transactions.
Market observers also note that geopolitical tensions and trade policy uncertainties could impact cross-border deal flow. However, strategic imperatives in key sectors may mitigate potential headwinds.
Investors and corporate leaders are watching interest rate trends closely. While the Federal Reserve eased some rate pressures in late 2025, ongoing inflation monitoring could influence capital costs and buyer decisions.
“The interplay between macroeconomic trends and strategic objectives will define deal opportunities in 2026,” said an M&A strategist at a global investment bank.
Smaller deals and middle-market transactions are expected to remain vigorous, presenting opportunities for emerging companies with specialized technologies or niche market positions.
Overall, the record of 2025 reinforces confidence in the resilience of the U.S. M&A market. Buyers and sellers alike appear prepared to leverage strategic combinations as a pathway to long-term growth.
